Open Access

Aucubin suppresses Titanium particles‑mediated apoptosis of MC3T3‑E1 cells and facilitates osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway

  • Authors:
    • Ziguan Zhu
    • Qingping Xie
    • Yazeng Huang
    • Shuijun Zhang
    • Yu Chen
  • View Affiliations

  • Published online on: July 16, 2018     https://doi.org/10.3892/mmr.2018.9286
  • Pages: 2561-2570
  • Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Aucubin represents an iridoid glucoside separated from multiple Chinese herbs, which has been demonstrated to possess numerous pharmacological activities. In the present study, the aim was to investigate the roles and mechanisms of aucubin in the suppression of mouse MC3T3‑E1 osteoblast apoptosis induced by Titanium particles and the promotion of bone formation. MTT assay and flow cytometry were performed to analyze cell viability and apoptosis, respectively. ELISA and para‑nitrophenyl phosphate colorimetry were carried out to evaluate the oxidative stress markers and alkaline phosphatase (ALP). Western blotting and reverse transcription‑quantitative polymerase chain reaction assays were used to evaluate the associated mRNA and protein expression. The results revealed that aucubin enhanced the cell activity of MC3T3‑E1 cells treated with Ti particles. Aucubin suppressed the apoptosis of Ti particles‑induced MC3T3‑E1 cells and facilitated osteogenesis by affecting the B‑cell lymphoma‑2 (Bcl‑2), Bcl‑2 associated X protein, ALP and associated osteogenic factors expression. Aucubin reduced the oxidative stress in Ti particles‑induced MC3T3‑E1 cells. In addition, aucubin upregulated the bone morphogenetic protein 2 (BMP2)/Smads/runt related transcription factor 2 (RunX2) pathway in Ti particles‑induced MC3T3‑E1 cells. In conclusion, the present study confirmed that aucubin suppressed the Ti particles‑mediated apoptosis of MC3T3‑E1 cells and facilitated osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway.

Introduction

The formation of bone tissues is a complex and orderly dynamic process regulated by bone growth factors of the organism (1). In this process, osteoblasts serve as the main functional cells of osteogenesis to responsible for the synthesis, secretion and mineralization of bone matrix (2,3). Various osteoblast specific genes such as collagen type I (COL I), alkaline phosphatase (ALP), and osteonectin (OPN) express in different periods of the osteoblast differentiation, which further produce the corresponding proteins and secrete to extracellular matrix thereby complete the osteogenesis (4). Moreover, osteocalcin (OCN) and osterix also serve as important factors in the development and process of osteogenesis (5). Previous studies have demonstrated that oxidative stress played a critical role in the progression of osteogenesis (68). As a consequence, the study of osteoblast differentiation and other regulatory mechanisms for the repair of bone tissues has important clinical significance.

Titanium (Ti) metal is characterized by better biocompatibility, hardness, inertia, and corrosion resistance, which has been widely used in the design and utilization of artificial arthroplasty (911). Ti particles have been proved to inhibit the mesenchymal stem cells (MSCs) osteoblast phenotype expression, bone sialoprotein (BSP) expression, cell proliferation, matrix mineralization and Type I collagen production (12). Furthermore, it also has been demonstrated that Ti particles could induce the apoptosis of MSCs (13). Different sizes of Ti particles and osteoblasts co-culturing could significantly reduce the expression levels of ALP, OPN, and OCN (14). And study has shown that Ti particles with a diameter of 1.5–4.0 µm could markedly suppress the proliferation and functions of osteoblasts (15). Nevertheless, there are few reports in regard to the therapeutic agents and pharmacological mechanisms of Ti particles-mediated osteoblast apoptosis.

Bone morphogenetic proteins (BMPs) are a kind of growth factors that can induce undifferentiated mesenchymal cells to disintegrate into cartilage and bone (16). Smads/runt related transcription factor 2 (RunX2) represents one of the major transduction pathways of BMPs to transmit signals to cells (17). In addition, Smad1/5/8 act as key molecules in the signaling pathway to regulate the target genes (1820). In order to promote the cell differentiation towards osteogenesis, BMPs bind to the promoter regions of corresponding osteoblast-specific ALP and OPN through down-stream transcription factors such as RunX2 and Osterix (21,22). Studies have found that RunX2 was regulated by BMPs via Smads signaling pathway, and RunX2 could upregulate the expression of bone matrix proteins, including OPN and OCN (2325). Nevertheless, we know little about the mechanisms of BMP2/Smads/RunX2 pathway in the Ti particles-induced osteoblasts apoptosis.

Aucubin represents an iridoid glucoside separated from multiple Chinese herbs involving leaves of Aucuba japonica and Eucommia ulmoides (26,27), which has been demonstrated to possess liver protective activities (28,29), anti-oxidative stress effects (30,31), and anti-inflammatory action (32). It has been well documented the extract of Eucommiae Cortex promoted the osteoblast proliferation and osteogenesis in postmenopausal osteoporosis (33). However, the therapeutic roles and accurate mechanisms of aucubin in the apoptosis of osteoblasts and osteogenesis have not been identified.

In our study, we explored whether aucubin could act as a novel therapeutic agent suppressing the apoptosis of MC3T3-E1 cells induced by Ti particles and facilitating osteogenesis. Furthermore, it was also fascinating to explore the related apoptosis proteins, osteogenic factors, and signal pathway expression in Ti particles-induced MC3T3-E1 cells treated with different concentration of aucubin.

Materials and methods

Reagents

The products used in cell culture in our study were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Antibodies and aucubin were purchased from Abcam (Cambridge, UK) and Sigma-Aldrich (Merck KGaA, Darmstadt, Germany), respectively. The Ti particles used in our study were obtained from XiLong Scientific Co., Ltd. (Shenzhen, China). The chemical composition of Ti was (wt%): Ti 99.3, Fe 0.039, O 0.35, N 0.035, C 0.025, Cl 0.034, H 0.024, and Si 0.0018. Sizing by means of Laser Particle Sizer (OMEC LS-POP III) revealed Ti particles had an average size of less than or equal to 5 µm (95.98 wt% of Ti particles were in the range 3–4 µm).

Cell culture

Mouse MC3T3-E1 osteoblast cell line was obtained from the Cell Bank of Chinese Academy of Sciences. MC3T3-E1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.) mixed with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) in a 5% CO2 atmosphere at 37°C. Afterwards, MC3T3-E1 cells were observed using an inverted microscope for growth status at 24, 48, and 72 h, respectively.

Ti particles treatment

Cells were trypsinized by 0.25% Trypsin (Beyotime Institute of Biotechnology, Shanghai, China) and seeded into the 6-well plates containing type I collagen. After 24 h, cells were attached to the wall of culture bottles. Culture medium was removed and replaced by 2% FBS to starve the cells for 16 h. Before the Ti particles treatment, 2% FBS was replaced by 1% FBS. Ti particles were dissolved in the phosphate-buffered solution (PBS; XiLong Scientific Co., Ltd.) and sterilized by autoclaved sterilization. After that, Ti particles (≤5 µm, 0.1 wt%; XiLong Scientific Co., Ltd.) were added into the cells.

Grouping

Here, five treatment groups were prepared for our study, including control group (cells treated with PBS), Ti group (cells coped with Ti particles), 0.1 µM aucubin + Ti group (cells preprocessed with 0.1 µM aucubin for 6 h, and then coped with Ti particles), 1 µM aucubin + Ti group (cells preprocessed with 1 µM aucubin for 6 h, and then coped with Ti particles), and 10 µM aucubin + Ti group (cells preprocessed with 10 µM aucubin for 6 h, and then coped with Ti particles).

Cell viability analysis

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was carried out to evaluate the cell vitality of MC3T3-E1 cells. MC3T3-E1 cells at a concentration of 5×103 per well were seeded into the 96-well plates and incubated in a 5% CO2 atmosphere at 37°C for 12 h. Afterwards, MC3T3-E1 cells were preprocessed with different concentration of aucubin (0.1, 1, and 10 µM) for 6 h. And then, the cells were coped with Ti particles prepared in advance for 12 h. After adding 10 µl of MTT solution (5 mg/ml; Amerco, Reno, NV, USA), MC3T3-E1 cells were maintained at 37°C for 6 h. After that, MC3T3-E1 cells were centrifuged at 1,000 × g for 1 min, and the supernatant was removed. Cells were then treated with 100 µl dimethyl sulfoxide (DMSO; XiLongScientific, Shenzhen, Guangdong, China) under low-speed oscillation for 10 min. The absorbance was detected at 490 nm wavelength using a microplate reader (BIO-RAD, California, USA). The cell viability and inhibition rate were calculated by the percentage of cell survival compared with control.

Apoptosis assay

Cell apoptosis was assessed by Flow cytometry (FCM). After washing by PBS, MC3T3-E1 cells were trypsinized by 0.25% Trypsin (Beyotime, Shanghai, China). MC3T3-E1 cells were centrifuged at 1,000 rpm/min for 1 min, and the supernatant was removed and the MC3T3-E1 cells for assessment were suspended in the incubation buffer at a density of 1×106 cells/ml. And then cells were maintained with Annexin V-FITC and propidium iodide (PI; XiLong Scientific Co., Ltd.) at room temperature for 15 min in the dark. After that, cell apoptosis was assessed by FACSCalibur (BD Biosciences, San Diego, CA, USA).

Para-nitrophenyl phosphate (pNPP) colorimetry

Alkaline Phosphatase Colorimetric Assay kit (TE0003; Leagene, Beijing, China) was used in the assessment of ALP activity. The supernatant was collected after lysates of MC3T3-E1 cells centrifuging at 1,000 × g for 1 min. The collected supernatant and ALP assay buffer were added into the 96-well plates according to the specification. Afterwards, the plates were blended and incubated for 30 min at 37°C. Then, stop solution was added into the wells to stop reaction. Finally, the absorbance at 405 nm was detected by microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Enzyme linked immunosorbent assay (ELISA)

The kits used for the assessment of ROS (S0033), MDA (S0131), LDH (C0017), SOD (S0101), and GPx (S0056) in MC3T3-E1 cells were obtained from Beyotime Institute of Biotechnology. MC3T3-E1 cells were added into the corresponding wells, and the wells were sealed up by adhesive tape and maintained at 37°C for 90 min. And then 100 µl biotinylated antibody fluids were added into each well except for the blank wells. Afterwards, wells were sealed by adhesive tape and maintained at 37°C for 60 min. Plates were washed by PBS and 100 µl enzyme solutions were added into each well. After that, wells were sealed up with adhesive tape and maintained at 37°C for 30 min. Chromogenic substrate was added into the wells except for the blank wells. Plates were maintained for 10–15 min in the dark at 37°C. Afterwards, stop solution was added into each well, and mixed in 10 min immediately. Finally, the OD450 value was detected by microplate reader (Bio-Rad Laboratories, Inc.).

Western blot analysis

Cell proteins lysates from MC3T3-E1 cells were partitioned by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a PVDF membrane (EMD Millipore, Billerica, MA, USA). Blotting was carried out with spectific antibodies [anti-B-cell lymphoma-2 (Bcl-2) associated X protein (Bax), 1:5,000 dilution, cat. no. ab32503; Abcam; anti-Bcl-2, 1:1,000 dilution, cat. no. ab692; Abcam; anti-OPN, 1:1,000 dilution, cat. no. ab8448; Abcam; anti-OCN, 1:1,000 dilution, cat. no. ab13418; Abcam; anti-Osterix, 1:1,000 dilution, cat. no. ab94744; Abcam; anti-BMP2, 1:500 dilution, cat. no. ab14933; Abcam; anti-Smad1, 1:1,000 dilution, cat. no. ab33902; Abcam; anti-Smad5, 1:1,000 dilution, cat. no. ab194661; Abcam; anti-Smad8, 1:5,000 dilution, cat. no. ab13723; Abcam; anti-RunX2, 1:500 dilution, cat. no. ab23981; Abcam; anti-β-actin, 1:1,000 dilution, cat. no. ab8227; Abcam]. After that, horseradish peroxidase-conjugated secondary antibodies (bs-0293M; Bioss, Beijing, China) were added and maintained at room temperature for 1 h. The results were assessed by enhanced chemiluminescent reagents (EMD Millipore) using an ECL system (Amersham Pharmacia, Piscataway, NJ, USA).

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

Total RNA was extracted from MC3T3-E1 cells by TRIzol reagent (Thermo Fisher Scientific, Inc.). Afterwards, two microliters of RNA was used for the cDNA synthesis with a first strand cDNA kit (Sigma-Aldrich; Merck KGaA) following the specification. RT-qPCR analysis was carried out using ABI 7500 Thermocycler (Applied Biosystems; Thermo Fisher Scientific, Inc.). PCR cycles were under the following conditions: 10 min pretreatment at 94°C, 96°C for 15 sec, 62°C for 45 sec (45 cycles), a final extension at 75°C for 10 min and held at 4°C. β-actin and GAPDH were utilized as the control of the input RNA level. The primers used in RT-qPCR analysis were designed by Invitrogen (Shanghai, China) and were revealed in Table I.

Table I.

Sequences of the primers used for reverse transcription-quantitative polymerase chain reaction.

Table I.

Sequences of the primers used for reverse transcription-quantitative polymerase chain reaction.

GeneDirectionSequence (5′-3′)Product (bp)
BaxForward TCTCCGGCGAATTGGAGATG253
Reverse CTCACGGAGGAAGTCCAGTG
Bcl-2Forward TGCGTGAAGGCTTGAGATGT201
Reverse TCCCCCTTTCCTAGACCCAG
OPNForward GCCACAAGTTTCACAGCCAC371
Reverse AAAATGCAGTGGCCGTTTGC
OCNForward GCACACCTAGCAGACACCAT320
Reverse GGGCAGCACAGGTCCTAAAT
OsterixForward TGCTATACTCTGGGGGCTCT296
Reverse ACAAAGCTCAGGGGGAATCG
BMP2Forward TGAGCAAAGTGCTTGCACAC360
Reverse AGCCCCCTGGAAGGGATTAT
Smad1Forward AGTGGGCTTTCATCAGGCTC318
Reverse TCTACATTTGCAGCCGTCGT
Smad5Forward TCTGGGAATTTCTTTGCCTTACC355
Reverse AATTGTTGGCCCAAAGCAGC
Smad8Forward TAAGTCACGTCGTCAGCCAC322
Reverse GTGTTTTCCATGTGGGGCAC
RunX2Forward AGCGGCAGAATGGATGAGTC280
Reverse ACCAGACAACACCTTTGACG
β-actinForward GTTACAGGAAGTCCCTCACCC194
Reverse CAGACCTGGGCCATTCAGAAA

[i] Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; OPN, osteonectin; OCN, osteocalcin; BMP2, bone morphogenetic protein 2; RunX2, runt related transcription factor 2; bp, base pairs.

Statistical analysis

Results in our study were showed as mean ± SEM of at least three independent experiments. Statistical analysis was performed using IBM SPSS statistical software (version 19; IBM Corp., Armonk, NY, USA). The differences in characteristics between the 2 groups in cell viability analysis, apoptosis assay, pNPP colorimetry, ELISA, western blot analysis, and RT-qPCR analysis were examined by Kruskal-Wallis and Tukey's test. P<0.05 was considered to indicate a statistically significant difference.

Results

The identification of MC3T3-E1 mouse osteoblast cell line

The morphologic characteristics of MC3T3-E1 mouse osteoblast cell line was observed by inverted microscope at 200 magnification times. As shown in Fig. 1A and B, we found that MC3T3-E1 cells attached to the wall of culture bottle and spread after culturing for 24 and 48 h. However, the confluence state of MC3T3-E1 cells was observed after culturing for 72 h (Fig. 1C). According to the previous literature, it has been proved that in logarithmic growth phase, MC3T3-E1 cells showed a fibroblastic morphology. The cell grew with a population doubling time. And on day 4 of culture, the cultures reached a confluent monolayer at a density of 5–6×104 cells/cm2, showing a mosaic appearance (34). Hence, based on our observation of the cultured cells, we confirmed that the cell line was MC3T3-E1 mouse osteoblast.

Aucubin enhanced the cell activity of MC3T3-E1 cells coped with Ti particles

MTT assay data (Fig. 2) revealed that the cell viability of MC3T3-E1 cells treated with Ti particles for 12 h (55.86±5.9%) was distinctly lower than control (100±0%). However, compared with the MC3T3-E1 cells coped with Ti particles, we found that the cell viability of Ti particles-induced MC3T3-E1 cells in aucubin preprocessing groups was obviously enhanced, especially in the 10 µM aucubin treatment group (86.96±4.5%). These consequences indicated that aucubin could enhance the cell viability of MC3T3-E1 cells suppressed by Ti particles.

Aucubin suppressed the apoptosis of Ti particles-induced MC3T3-E1 cells

As FCM data revealed in Fig. 3, the percentage of apoptosis MC3T3-E1 cell number in Ti group was 20.13±2.06%, which was markedly higher than control (6.44±0.42%). Nevertheless, after treating with different concentration of aucubin, the apoptosis rate of MC3T3-E1 cells was reduced to 14.71±1.02, 11.15±0.89, and 8.94±0.65%, respectively. These data indicated that aucubin significantly weakened the apoptosis capacity of MC3T3-E1 cells which was enhanced by Ti particles. In addition, we also studied the apoptosis-associated proteins expression in MC3T3-E1 cells. According to the RT-qPCR and western blot data, we found that the Bax expression in Ti group (6.62±0.31) was significantly higher than control (1±0.05), while the Bax expression in Ti particles-induced MC3T3-E1 cells was obviously lessened by aucubin (3.73±0.15, 2.37±0.12, 1.52±0.25; Fig. 4A and B). However, we also found that Ti particles markedly reduced the expression level of Bcl-2 in MC3T3-E1 cells (0.16±0.01), while aucubin could evidently upregulate the Bcl-2 expression in Ti particles-induced MC3T3-E1 cells (0.72±0.02, 0.85±0.04, and 0.96±0.04; Fig. 4A and B). Based on these consequences, we confirmed that aucubin suppressed the apoptosis of Ti particles-induced MC3T3-E1 cells through regulating the Bax and Bcl-2 expression.

Aucubin reduced the oxidative stress in Ti particles-induced MC3T3-E1 cells

Malondialdehyde (MDA), lactate dehydrogenase (LDH), reactive oxygen species (ROS), glutathione peroxidase (GPx), and superoxide dismutase (SOD) represent the most important markers of oxidative stress in cellula. In our investigation, ELISA was carried out to evaluate the levels of oxidative stress markers in MC3T3-E1 cells treated with Ti particles and different concentration of aucubin. According to the results, we found that the ROS (18.23±1.20), MDA (1.56±0.09), and LDH (129.89±3.00) content in MC3T3-E1 cells treated with Ti particles were markedly higher than control, while aucubin significantly lessened the ROS (15.63±1.00, 12.03±0.89, and 8.99±0.56), MDA (1.25±0.08, 1.03±0.01, and 0.59±0.03), and LDH (112.36±2.90, 108.56±2.50, and 85.36±3.10) content in Ti particles-induced MC3T3-E1 cells (Fig. 5A-C). Nevertheless, Ti particles were observed to reduce the SOD (55.23±15.37) and GPx (7.96±0.23) activities in MC3T3-E1 cells. After treating with different concentration of aucubin, the SOD (69.36±18.45, 98.02±20.30, and 128.69±18.36) and GPx (9.89±0.23, 12.23±0.33, and 14.52±0.41) activity in Ti particles-induced MC3T3-E1 cells was distinctly enhanced (Fig. 5D and E). To sum up, we confirmed that aucubin reduced the ROS, MDA, and LDH content, while enhanced the SOD and GPx activity in Ti particles-induced MC3T3-E1 cells. Due to the modulation of oxidative markers in Ti particles-induced MC3T3-E1 cells, it was demonstrated that aucubin reduced the oxidative stress in Ti particles-induced MC3T3-E1 cells.

Aubucin facilitated osteogenesis through regulating the related osteogenic factors expression

In order to explore the effects of aucubin in bone formation, we further studied the related osteogenic factors expression in MC3T3-E1 cells coped with Ti particles and aucubin. The pNPP colorimetry data indicated that activity of ALP in MC3T3-E1 cells was markedly reduced by Ti particles (10.02±0.23), while increases were observed in Ti particles-induced MC3T3-E1 cells treated with aucubin (28.50±0.98, 35.20±1.85, and 45.90±2.89; Fig. 5F). Moreover, the mRNA expression levels of OPN (0.24±0.05), OCN (0.38±0.01), and Osterix (0.13±0.01) in MC3T3-E1 cells were significantly decreased by Ti particles (Fig. 6A). After treating with different concentration of aucubin, the OPN (0.33±0.01, 0.53±0.03, and 0.65±0.02), OCN (0.75±0.03, 0.73±0.03, and 0.85±0.04), and Osterix (0.33±0.01, 0.46±0.02, and 0.64±0.03) expression in Ti particles-induced MC3T3-E1 cells was markedly enhanced (Fig. 6A). Additionally, the protein expression levels of OPN (0.14±0.01; 0.21±0.01, 0.33±0.03, and 0.51±0.03), OCN (0.11±0.01; 0.22±0.01, 0.27±0.02, and 0.38±0.02), and Osterix (0.16±0.01; 0.25±0.01, 0.35±0.02, and 0.55±0.02) in MC3T3-E1 cells treated with Ti particles and aucubin verified the RT-qPCR results (Fig. 6B). Hence, it was determined that Ti particles suppressed the OPN, OCN, and Osterix expression in MC3T3-E1 cells, while aucubin strengthened the OPN, OCN, and Osterix expression in Ti particles-induced MC3T3-E1 cells. According to these conclusions, we conjectured that aucubin facilitated osteogenesis through enhancing the activity of ALP and upregulating the osteogenesis-related genes expression.

Aucubin affected the BMP2/Smads/RunX2 pathway

Furthermore, we assessed the BMP2, Smad1/5/8, and RunX2 expression in MC3T3-E1 cells from each group. The RT-qPCR and western blot results indicated that the BMP2 (0.08±0.001), Smad1 (0.24±0.01)/5 (0.02±0.001)/8 (0.35±0.001), and RunX2 (0.21±0.01) expression in MC3T3-E1 cells coped with Ti particles were significantly lower than control. However, distinct increases of BMP2 (0.33±0.01, 0.43±0.02, and 0.71±0.02), Smad1 (0.44±0.02, 0.67±0.02, and 0.81±0.04)/5 (0.54±0.02, 0.80±0.03, and 0.85±0.02)/8 (0.56±0.02, 0.67±0.03, and 0.86±0.04), and RunX2 (0.52±0.02, 0.71±0.03, and 0.89±0.02) expression were observed in the Ti particles-induced MC3T3-E1 cells treated with aucubin (Fig. 7A-C). Therefore, it was affirmed that BMP2/Smads/RunX2 pathway could be upregulated by aucubin in MC3T3-E1 cells induced by Ti particles.

Discussion

In the traditional sense, osteoblasts are mainly derived from the primary cell culture of living tissues, which is closer to the physiological condition of organism (35). However, in vitro culture of primary cells susceptible to extraction conditions, culture environment, and other factors, which might impact the cell proliferation and differentiation of osteoblasts. In addition, different batches of primary cells often unable to maintain the genetic stability (36). Thus, we chose MC3T3-E1 cells as the study object in the current research. MC3T3-E1 cell line was first separated from the newborn C57BL/6 mouse skull bone and established as osteoblasts cell line by a Japanese scholar Kodama in 1981 (34). MC3T3-E1 cell line possesses stable proliferation, infinite cell passage function, and multiple biological characteristics of osteoblasts, involving ALP activity, COLI synthesis, and matrix mineralization. Hence, MC3T3-E1 cells were often used as the cell model in the bone metabolism research (37,38).

Aucubin represents an iridoid glucoside separated from multiple Chinese herbs involving leaves of Aucuba japonica and Eucommia ulmoides, which has been demonstrated to possess numerous pharmacological activities (26,27). It has been reported that the components of Eucommiae Cortex activated the osteoblast and further facilitated osteogenesis (33). Recent study also has proved that the extract of Eucommia ulmoides leaves antagonized H2O2-induced mouse MC3T3-E1 apoptosis via suppressing the expression of Caspases 3/6/7/9 (39). Up to now, although many studies were in regard to aucubin and osteoblasts, the apoptosis and related mechanisms of Ti particles-induced osteoblasts treated with aucubin is not clear. In our study, it was confirmed that aucubin evidently enhanced the cell activity of Ti particles-induced MC3T3-E1 cells. Hence, we conjectured whether aucubin posesses the functions in the suppression of MC3T3-E1 cell apoptosis. We further evaluated the effect of Ti particles and aucubin on the apoptosis of MC3T3-E1 cells. Experimental data indicated that Ti particles led to high percentage of apoptosis cell number, while aucubin significantly inhibited the apoptosis of Ti particles-induced MC3T3-E1 cells. Furthermore, the apoptosis-associated mechanisms in MC3T3-E1 cells coped with Ti particles and aucubin were investigated. It was revealed that aucubin obviously reduced the Bax expression, while upregulated the Bcl-2 expression in Ti particles-induced MC3T3-E1 cells. Therefore, we could draw the conclusion that aucubin inhibited the Ti particles-mediated apoptosis of MC3T3-E1 cells through regulating the expression levels of Bax and Bcl-2.

Mitochondria play a crucial part in the cell growth and death and possess the function of ROS generation and detoxification (40,41). It has been demonstrated that at high concentration, ROS might lead to severe injury to cells, which referred to the ‘oxidative stress’ (4244). Aucubin has been reported that possessed the anti-oxidation activity (45,46). Due to the ability of aucubin in the suppression of MC3T3-E1 cell apoptosis, it was arrestive that whether aucubin could affect the oxidative stress in MC3T3-E1 cells. Hence, we assessed the oxidative stress markers in MC3T3-E1 cells treated with aucubin, including ROS, MDA, LDH, SOD, and GPx. Obvious reductions of ROS, MDA, and LDH content were observed in the Ti particles-induced MC3T3-E1 cells treated with aucubin. Additionally, we also found that aucubin enhanced the activities of SOD and GPx in Ti particles-induced MC3T3-E1 cells. Thus, according to these results, it was confirmed that aucubin distinctly reduced the oxidative stress activated by Ti particles. At present, we proved that aucubin possessed the functions of suppressing the apoptosis and reducing the oxidative stress of Ti particles-induced MC3T3-E1 cells. Thus, the protective effects of aucubin on the MC3T3-E1 cells induced by Ti particles were demonstrated. Moreover, on account of MC3T3-E1 cells play an important role in the progression of osteogenesis. We thereby speculated that aucubin might impact the osteogenesis.

Based on the previous study (47), ALP, OPN, OCN, and Osterix were selected as osteoblast specific factors to evaluate the effect of aucubin in osteogenesis. In the current study, MC3T3-E1 cells acted as precursor osteoblasts, which could be gradually differentiated into osteoblasts in the specific medium. We found that the ALP activity, OPN, OCN, and Osterix expression in Ti particles-induced MC3T3-E1 cells was enhanced by aucubin. In consequence, it was proved that aucubin might facilitate osteogenesis through enhancing ALP activity and upregulating the expression levels of OPN, OCN, and Osterix in Ti particles-induced MC3T3-E1 cells.

Additionally, previous studies also have indicated that BMP2/Smads/RunX2 pathway might participate in the apoptosis and the process of osteogenesis (48,49). Nevertheless, the accurate role and mechanism of aucubin in the regulation of BMP2/Smads/RunX2 pathway in osteoblasts apoptosis and osteogenesis is unclear. Thus, we further explored the probable mechanism of BMP2/Smads/RunX2 pathway in the suppression of osteoblasts apoptosis and promotion of osteogenesis. According to the western blot data, it was confirmed that the BMP2, Smad1/5/8, and RunX2 expression in Ti particles-induced MC3T3-E1 cells was strengthened by aucubin. Thus, we confirmed that aucubin could impact the BMP2/Smads/RunX2 pathway in Ti particles-induced MC3T3-E1 cells. All together, to the best of our knowledge, it was first proved that aucubin inhibited Ti particles-induced MC3T3-E1 cell apoptosis and facilitated osteogenesis by upregulating BMP2/Smads/RunX2 pathway.

In summary, our present work highlights that aucubin suppressed Ti particles-mediated apoptosis of MC3T3-E1 cells and facilitated osteogenesis through affecting BMP2/Smads/RunX2 pathway. The findings of our research have crucial influence on the mechanisms of aucubin and osteoblasts. The potential effects of aucubin on the promotion of osteogenesis suggest that aucubin might be an effective target for osteogenesis promotion.

Acknowledgements

Not applicable.

Funding

This work was supported by Zhejiang Provincial Medical Science and Technology on General Item (grant nos. 2015KYA014 and 2017KY011).

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Authors' contributions

YC designed the experiments and wrote the article. ZZ conducted the cell culture and treatment sections, and analysed the function of Aucubin on the BMP2/Smads/RunX2 pathway. QX performed the MTT and flow cytometry assays to detect cell viability and apoptosis. SZ carried out ELISA and para-nitrophenyl phosphate colorimetry to evaluate the oxidative stress markers and alkaline phosphatase levels. YH was involved in the detection of the expression levels of apoptosis-associated factors.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Caetano-Lopes J, Canhão H and Fonseca JE: Osteoblasts and bone formation. Acta Reumatol Port. 32:103–110. 2007.PubMed/NCBI

2 

Hadjidakis D and Androulakis II: Bone remodeling. Ann N Y Acad Sci. 1092:385–396. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Ruff CB, Garofalo E and Holmes MA: Interpreting skeletal growth in the past from a functional and physiological perspective. Am J Phys Anthropol. 150:29–37. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Gowri AM, Kavitha G, Rajasundari M, Fathima SM, Kumar TM and Raj GD: Foetal stem cell derivation & characterization for osteogenic lineage. Indian J Med Res. 137:308–315. 2013.PubMed/NCBI

5 

Gronthos S, Chen S, Wang CY, Robey PG and Shi S: Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res. 18:716–722. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Rajamannan NM: Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(−/−) null mice. J Cell Biochem. 113:1623–1634. 2012.PubMed/NCBI

7 

Wang F, Yin P, Lu Y, Zhou Z, Jiang C, Liu Y and Yu X: Cordycepin prevents oxidative stress-induced inhibition of osteogenesis. Oncotarget. 6:35496–35508. 2015.PubMed/NCBI

8 

Wang N, Wang F, Gao Y, Yin P, Pan C, Liu W, Zhou Z and Wang J: Curcumin protects human adipose-derived mesenchymal stem cells against oxidative stress-induced inhibition of osteogenesis. J Pharmacol Sci. 132:192–200. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Galetz MC, Fleischmann EW, Konrad CH, Schuetz A and Glatzel U: Abrasion resistance of oxidized zirconium in comparison with CoCrMo and titanium nitride coatings for artificial knee joints. J Biomed Mater Res B Appl Biomater. 93:244–251. 2010.PubMed/NCBI

10 

Grübl A, Chiari C, Gruber M, Kaider A and Gottsauner-Wolf F: Cementless total hip arthroplasty with a tapered, rectangular titanium stem and a threaded cup: A minimum ten-year follow-up. J Bone Joint Surg Am. 84-A:425–431. 2002. View Article : Google Scholar : PubMed/NCBI

11 

Lombardi AV Jr, Mallory TH, Vaughn BK and Drouillard P: Aseptic loosening in total hip arthroplasty secondary to osteolysis induced by wear debris from titanium-alloy modular femoral heads. J Bone Joint Surg Am. 71:1337–1342. 1989. View Article : Google Scholar : PubMed/NCBI

12 

Wang ML, Nesti LJ, Tuli R, Lazatin J, Danielson KG, Sharkey PF and Tuan RS: Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res. 20:1175–1184. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Wang ML, Tuli R, Manner PA, Sharkey PF, Hall DJ and Tuan RS: Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res. 21:697–707. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Zreiqat H, Crotti TN, Howlett CR, Capone M, Markovic B and Haynes DR: Prosthetic particles modify the expression of bone-related proteins by human osteoblastic cells in vitro. Biomaterials. 24:337–346. 2003. View Article : Google Scholar : PubMed/NCBI

15 

O'Connor DT, Choi MG, Kwon SY and Sung Paul KL: New insight into the mechanism of hip prosthesis loosening: Effect of titanium debris size on osteoblast function. J Orthop Res. 22:229–236. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Chenard KE, Teven CM, He TC and Reid RR: Bone morphogenetic proteins in craniofacial surgery: Current techniques, clinical experiences, and the future of personalized stem cell therapy. J Biomed Biotechnol. 2012:6015492012. View Article : Google Scholar : PubMed/NCBI

17 

De Caestecker M and Meyrick B: Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension. Respir Res. 2:193–197. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Axelrad TW and Einhorn TA: Bone morphogenetic proteins in orthopaedic surgery. Cytokine Growth Factor Rev. 20:481–488. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Conidi A, Cazzola S, Beets K, Coddens K, Collart C, Cornelis F, Cox L, Joke D, Dobreva MP, Dries R, et al: Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo. Cytokine Growth Factor Rev. 22:287–300. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Simic P and Vukicevic S: Bone morphogenetic proteins: From developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Rep. 8:327–331. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R and Yoneda T: BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem. 283:29119–29125. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Nishimura R, Hata K, Matsubara T, Wakabayashi M and Yoneda T: Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J Biochem. 151:247–254. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Komori T: Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol. 658:43–49. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Saito T, Ogawa M, Hata Y and Bessho K: Acceleration effect of human recombinant bone morphogenetic protein-2 on differentiation of human pulp cells into odontoblasts. J Endod. 30:205–208. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Chang LM, Yun HS, Kim YS and Ahn JW: Aucubin: Potential antidote for alpha-amanitin poisoning. J Toxicol Clin Toxicol. 22:77–85. 1984. View Article : Google Scholar : PubMed/NCBI

27 

Li Y, Sato T, Metori K, Koike K, Che QM and Takahashi S: The promoting effects of geniposidic acid and aucubin in Eucommia ulmoides Oliver leaves on collagen synthesis. Biol Pharm Bull. 21:1306–1310. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Chang IM: Liver-protective activities of aucubin derived from traditional oriental medicine. Res Commun Mol Pathol Pharmacol. 102:189–204. 1998.PubMed/NCBI

29 

Chang IM, Ryu JC, Park YC, Yun HS and Yang KH: Protective activities of aucubin against carbon tetrachloride-induced liver damage in mice. Drug Chem Toxicol. 6:443–453. 1983. View Article : Google Scholar : PubMed/NCBI

30 

Jin L, Xue HY, Jin LJ, Li SY and Xu YP: Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol. 582:162–167. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Xue HY, Gao GZ, Lin QY, Jin LJ and Xu YP: Protective effects of aucubin on H2O2-induced apoptosis in PC12 cells. Phytother Res. 26:369–374. 2012.PubMed/NCBI

32 

Xue H, Jin L, Jin L, Zhang P, Li D, Xia Y, Lu Y and Xu Y: Neuroprotection of aucubin in primary diabetic encephalopathy. Sci China C Life Sci. 51:495–502. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Ha H, Ho J, Shin S, Kim H, Koo S, Kim IH and Kim C: Effects of Eucommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch Pharm Res. 26:929–936. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Sudo H, Kodama HA, Amagai Y, Yamamoto S and Kasai S: In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI

35 

Czekanska EM, Stoddart MJ, Richards RG and Hayes JS: In search of an osteoblast cell model for in vitro research. Eur Cell Mater. 24:1–17. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Chen G, Deng C and Li YP: TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 8:272–288. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Aubin JE and Turksen K: Monoclonal antibodies as tools for studying the osteoblast lineage. Microsc Res Tech. 33:128–140. 1996. View Article : Google Scholar : PubMed/NCBI

38 

Matsumoto A: The effect of cell environment on osteoblastic function. Nihon Yakurigaku Zasshi. 105:273–283. 1995.(In Japanese). View Article : Google Scholar : PubMed/NCBI

39 

Lin J, Fan YJ, Mehl C, Zhu JJ, Chen H, Jin LY, Xu JH and Wang HM: Eucommia ulmoides Oliv. antagonizes H2O2-induced rat osteoblastic MC3T3-E1 apoptosis by inhibiting expressions of caspases 3, 6, 7, and 9. J Zhejiang Univ Sci B. 12:47–54. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Akopova OV, Kolchinskaya LI, Nosar VI, Bouryi VA, Mankovska IN and Sagach VF: Cytochrome C as an amplifier of ROS release in mitochondria. Fiziol Zh. 58:3–12. 2012.

41 

Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, Missiroli S, Patergnani S, Poletti F, et al: Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct. 2012:3296352012. View Article : Google Scholar : PubMed/NCBI

42 

Cadenas E and Davies KJ: Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 29:222–230. 2000. View Article : Google Scholar : PubMed/NCBI

43 

Halliwell B and Gutteridge JM: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 186:1–85. 1990. View Article : Google Scholar : PubMed/NCBI

44 

Lenaz G, Bovina C, Formiggini G and Castelli Parenti G: Mitochondria, oxidative stress, and antioxidant defences. Acta Biochim Pol. 46:1–21. 1999.PubMed/NCBI

45 

Ho JN, Lee YH, Lee YD, Jun WJ, Kim HK, Hong BS, Shin DH and Cho HY: Inhibitory effect of Aucubin isolated from Eucommia ulmoides against UVB-induced matrix metalloproteinase-1 production in human skin fibroblasts. Biosci Biotechnol Biochem. 69:2227–2231. 2005. View Article : Google Scholar : PubMed/NCBI

46 

Ho JN, Lee YH, Park JS, Jun WJ, Kim HK, Hong BS, Shin DH and Cho HY: Protective effects of aucubin isolated from Eucommia ulmoides against UVB-induced oxidative stress in human skin fibroblasts. Biol Pharm Bull. 28:1244–1248. 2005. View Article : Google Scholar : PubMed/NCBI

47 

Park KW, Waki H, Kim WK, Davies BS, Young SG, Parhami F and Tontonoz P: The small molecule phenamil induces osteoblast differentiation and mineralization. Mol Cell Biol. 29:3905–3914. 2009. View Article : Google Scholar : PubMed/NCBI

48 

Eliseev RA, Dong YF, Sampson E, Zuscik MJ, Schwarz EM, O'Keefe RJ, Rosier RN and Drissi MH: Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene. 27:3605–3614. 2008. View Article : Google Scholar : PubMed/NCBI

49 

Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS and Lian JB: Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 280:33132–33140. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September-2018
Volume 18 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu Z, Xie Q, Huang Y, Zhang S and Chen Y: Aucubin suppresses Titanium particles‑mediated apoptosis of MC3T3‑E1 cells and facilitates osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway. Mol Med Rep 18: 2561-2570, 2018
APA
Zhu, Z., Xie, Q., Huang, Y., Zhang, S., & Chen, Y. (2018). Aucubin suppresses Titanium particles‑mediated apoptosis of MC3T3‑E1 cells and facilitates osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway. Molecular Medicine Reports, 18, 2561-2570. https://doi.org/10.3892/mmr.2018.9286
MLA
Zhu, Z., Xie, Q., Huang, Y., Zhang, S., Chen, Y."Aucubin suppresses Titanium particles‑mediated apoptosis of MC3T3‑E1 cells and facilitates osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway". Molecular Medicine Reports 18.3 (2018): 2561-2570.
Chicago
Zhu, Z., Xie, Q., Huang, Y., Zhang, S., Chen, Y."Aucubin suppresses Titanium particles‑mediated apoptosis of MC3T3‑E1 cells and facilitates osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway". Molecular Medicine Reports 18, no. 3 (2018): 2561-2570. https://doi.org/10.3892/mmr.2018.9286